1999
Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
Lianidou E, Levesque M, Katsaros D, Angelopoulou K, Yu H, Genta F, Arisio R, Massobrio M, Bharaj B, Diamandis E. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma. Anticancer Research 1999, 19: 749-56. PMID: 10216487.Peer-Reviewed Original ResearchConceptsP53 protein accumulationOvarian carcinomaP53 abnormalitiesP53 mutationsP53 proteinMissense point mutationsPrimary epithelial ovarian carcinomaEpithelial ovarian carcinomaGrade 3 lesionsCM-1 antibodyP53 protein overexpressionP53 exons 5Exon 5Unfavorable prognosisMutant p53 proteinP53 alterationsSerous histotypeClinical valueStage IIIDO-1Most malignanciesImmunofluorometric assayCarcinomaTumor tissueProtein accumulation
1995
Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.
Yu H, Diamandis E, Levesque M, Asa S, Monne M, Croce C. Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Research 1995, 55: 1603-6. PMID: 7536128.Peer-Reviewed Original ResearchMeSH KeywordsBase SequenceBlotting, SouthernBudd-Chiari SyndromeChromatography, High Pressure LiquidDNA PrimersDNA, NeoplasmFemaleGene ExpressionGlucocorticoidsHumansImmunohistochemistryLiver TransplantationMiddle AgedMolecular Sequence DataOvarian NeoplasmsPolymerase Chain ReactionProstate-Specific AntigenConceptsProstate-specific antigenPrimary ovarian carcinomasLiver transplantationOvarian tumorsOvarian carcinomaPSA geneProstate-specific antigen geneBreast carcinoma cell linesCarcinoma cell linesPSA cDNAProstate tissueTumor tissueTumorsEpithelial cellsTranscription-PCRWhole coding sequencePatientsTransplantationCarcinomaCell linesImmunohistochemistryAntigen geneTissue culture experimentsTissueDNA sequencing